We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-15.72%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$4.46B
AUM Growth
-$6B
Cap. Flow
-$4.51B
Cap. Flow %
-101.07%
Top 10 Hldgs %
21.21%
Holding
7,134
New
733
Increased
2,939
Reduced
2,324
Closed
739

Top Buys

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$41.1M
2
IWD icon
iShares Russell 1000 Value ETF
IWD
+$25.3M
3
DIA icon
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
+$18.4M
4
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$15.7M
5
XLK icon
State Street Technology Select Sector SPDR ETF
XLK
+$15.4M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$411M
2
MSFT icon
Microsoft
MSFT
+$372M
3
AMZN icon
Amazon
AMZN
+$192M
4
TSLA icon
Tesla
TSLA
+$121M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$111M

Sector Composition

Rank Sector Weight
1 Technology 22.54%
2 Healthcare 10.8%
3 Consumer Discretionary 9.19%
4 Financials 8.28%
5 Communication Services 7.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMRS
3201
DELISTED
Amyris Inc.
AMRS
$36K ﹤0.01%
19,669
+16,019
+439% +$47.1K
PSTH
3202
DELISTED
Pershing Square Tontine Holdings, Ltd.
PSTH
$36K ﹤0.01%
1,787
-837
-32% -$16.6K
CALA
3203
DELISTED
Calithera Biosciences, Inc
CALA
$36K ﹤0.01%
+14,503
New +$67.2K
EBIX
3204
DELISTED
Ebix Inc
EBIX
$36K ﹤0.01%
2,138
-812
-28% -$22.7K
ACLX
3205
DELISTED
Arcellx
ACLX
$35K ﹤0.01%
1,954
+1,307
+202% +$16.9K
BTAI icon
3206
BioXcel Therapeutics
BTAI
$32.4M
$35K ﹤0.01%
164
-43
-21% -$9.04K
CBAN icon
3207
Colony Bankcorp
CBAN
$469M
$35K ﹤0.01%
2,339
+2,059
+735% +$34.3K
CM icon
3208
Canadian Imperial Bank of Commerce
CM
$110B
$35K ﹤0.01%
725
-59,277
-99% -$3.23M
CMP icon
3209
Compass Minerals
CMP
$1.1B
$35K ﹤0.01%
985
-4,677
-83% -$231K
DBI icon
3210
Designer Brands
DBI
$320M
$35K ﹤0.01%
2,693
-13,519
-83% -$195K
GAIN icon
3211
Gladstone Investment Corp
GAIN
$658M
$35K ﹤0.01%
2,506
-3,726
-60% -$56.1K
INGN icon
3212
Inogen
INGN
$156M
$35K ﹤0.01%
1,429
+1,116
+357% +$29.6K
IX icon
3213
ORIX
IX
$43.9B
$35K ﹤0.01%
+2,105
New +$38.2K
MATV icon
3214
Mativ Holdings
MATV
$700M
$35K ﹤0.01%
1,413
+62
+5% +$1.64K
METC icon
3215
Ramaco Resources Class A
METC
$677M
$35K ﹤0.01%
2,722
+2,349
+630% +$35.3K
OUST icon
3216
Ouster
OUST
$3.25B
$35K ﹤0.01%
2,180
+1,399
+179% +$39.2K
PGEN icon
3217
Precigen
PGEN
$2.42B
$35K ﹤0.01%
25,828
-348
-1% -$516
PRDO icon
3218
Perdoceo Education
PRDO
$1.93B
$35K ﹤0.01%
2,992
-61,422
-95% -$673K
PRG icon
3219
PROG Holdings
PRG
$1.66B
$35K ﹤0.01%
2,096
-31,449
-94% -$805K
RDVT icon
3220
Red Violet
RDVT
$1.1B
$35K ﹤0.01%
1,824
+1,455
+394% +$35.8K
RNW icon
3221
ReNew
RNW
$2.48B
$35K ﹤0.01%
5,413
-10,224
-65% -$73.7K
SFL icon
3222
SFL Corp
SFL
$1.55B
$35K ﹤0.01%
3,690
+2,546
+223% +$26.5K
SFST icon
3223
Southern First Bancshares
SFST
$605M
$35K ﹤0.01%
794
+178
+29% +$8.09K
VB icon
3224
Vanguard Morningstar Small-Cap ETF
VB
$82.8B
$35K ﹤0.01%
200
-238
-54% -$46K
VERV
3225
DELISTED
Verve Therapeutics
VERV
$35K ﹤0.01%
2,324
-1,500
-39% -$23.2K
127 128
129
130 131

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
BHC
Bowen Hanes & Co Ponte Vedra Beach, Florida $4.11B AUM 41.61% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
SP
Stockbridge Partners Boston, Massachusetts $4.14B AUM 16.9% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return

Tower Research Capital (TRC)'s Q2 2022 Portfolio in Review

As of Q2 2022, Tower Research Capital (TRC) held 7,134 positions worth $4.46B, down 57% from $10.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Tower Research Capital (TRC) withdrew a net $4.51B in Q2 2022, closing 739 positions and reducing 2,324 holdings. Its most notable exit was iShares MSCI USA Value Factor ETF, an estimated $13.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Russell 1000 Value ETF worth $23.4M.

  • Tower Research Capital (TRC)'s largest Q2 2022 buy was iShares Russell 1000 Value ETF: 161,690 shares worth $23.4M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q2 2022, an estimated $41.1M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2022 reduction was Apple, cutting an estimated $411M.
  • Tower Research Capital (TRC) fully exited iShares MSCI USA Value Factor ETF in Q2 2022, selling an estimated $13.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 21% of its $4.46B portfolio in Q2 2022.
  • Tower Research Capital (TRC) opened 733 new positions and closed 739 in Q2 2022.
  • Tower Research Capital (TRC)'s portfolio value fell 57% quarter-over-quarter to $4.46B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2022, filed 15 Aug 2022.